Adrian Bot

Adrian Bot

Company: Capstan Therapeutics

Job title: CSO


Next-Generation In Vivo Immune Engineering Platforms: Considerations & Learnings to Optimise Transfer 9:00 am

Attend this workshop to: Understand the differences, advantages and limitations of both ex vivo and in vivo approaches Evaluate engineering methods and delivery platforms to ensure specific CAR expression in target tissue Evaluate in vivo modalities from lipid nanoparticles to viral vectors to outline options for cost, payload and scalability Discuss the possibility for in…Read more

day: Workshop A - AM

Industry Leaders’ Fireside Chat: The Opportunity for Next-Gen 8:40 am

Instilling the importance for innovative platforms and technologies to further enhance cell therapy efficacy Reviewing clinical advances of next generation programmes across solid tumours and autoimmunityRead more

day: Conference Day 1 - AM

A Hanson Wade Group Company

© Copyright 2024 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.